Durham

Mar 22
4 min read

First Chikungunya Vaccine Approved for Adolescents

VIMKUNYA is the first virus-like particle single-dose chikungunya vaccine
vaccine
Chikungunya
Dec 19
4 min read

Newest Chikungunya Vaccine Candidate's Benefits Are Measurable

Chikungunya outbreaks continue in 2024
vaccine
Chikungunya
Aug 12
4 min read

Uncomplicated UTI CRISPR-Cas3 Treatment Shows Positive Results

LBP-EC01 is a CRISPR-Cas3 genetically engineered bacteriophage therapy designed to treat patients with uncomplicated urinary tract infections caused by antimicrobial-resistant and multi-drug-resistant Escherichia coli
UTI
Urinary Track Infection (UTI)